标题
Enhancing Endocannabinoid Control of Stress with Cannabidiol
作者
关键词
-
出版物
Journal of Clinical Medicine
Volume 10, Issue 24, Pages 5852
出版商
MDPI AG
发表日期
2021-12-14
DOI
10.3390/jcm10245852
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Food Effects on the Formulation, Dosing, and Administration of Cannabidiol (CBD) in Humans: A Systematic Review of Clinical Studies
- (2021) Lucy H. Silmore et al. PHARMACOTHERAPY
- Cannabinoid receptor 1 signalling modulates stress susceptibility and microglial responses to chronic social defeat stress
- (2021) Eva C. Beins et al. Translational Psychiatry
- The Effects of Food on Cannabidiol Bioaccessibility
- (2021) Khadijeh Mozaffari et al. MOLECULES
- A pilot safety, tolerability and pharmacokinetic study of an oro-buccal administered cannabidiol-dominant anti-inflammatory formulation in healthy individuals: a randomized placebo-controlled single-blinded study
- (2021) Luis Vitetta et al. INFLAMMOPHARMACOLOGY
- Efficacy and Safety of Cannabidiol Plus Standard Care vs Standard Care Alone for the Treatment of Emotional Exhaustion and Burnout Among Frontline Health Care Workers During the COVID-19 Pandemic
- (2021) José Alexandre S. Crippa et al. JAMA Network Open
- Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment
- (2021) Tibor Stark et al. PHARMACOLOGICAL RESEARCH
- Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis
- (2020) E. Appiah-Kusi et al. PSYCHOPHARMACOLOGY
- CBD (Cannabidiol) Product Attitudes, Knowledge, and Use Among Young Adults
- (2020) Meghann Wheeler et al. SUBSTANCE USE & MISUSE
- Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment
- (2020) Tibor Stark et al. BIOCHEMICAL PHARMACOLOGY
- Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats
- (2020) Martina Di Bartolomeo et al. PHARMACOLOGICAL RESEARCH
- Cannabidiol: pharmacology and therapeutic targets
- (2020) Stevie C. Britch et al. PSYCHOPHARMACOLOGY
- A Phase 1, Open‐Label, Parallel‐Group, Single‐Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment
- (2019) Lesley Taylor et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use
- (2019) Joshua D. Brown et al. Journal of Clinical Medicine
- Cannabis and Pain
- (2019) Ethan B Russo PAIN MEDICINE
- Endocannabinoid system, Stress and HPA axis
- (2018) Vincenzo Micale et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling
- (2018) Manoela V. Fogaça et al. NEUROPHARMACOLOGY
- Stress and Heart Rate Variability: A Meta-Analysis and Review of the Literature
- (2018) Hye-Geum Kim et al. Psychiatry Investigation
- Role of the endocannabinoid system in drug addiction
- (2018) Jorge Manzanares et al. BIOCHEMICAL PHARMACOLOGY
- Cannabidiol modulates serotonergic transmission and prevents allodynia and anxiety-like behavior in a model of neuropathic pain
- (2018) Danilo De Gregorio et al. PAIN
- A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
- (2018) Lesley Taylor et al. CNS DRUGS
- Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial
- (2018) Kerri A. Schoedel et al. EPILEPSY & BEHAVIOR
- Cannabidiol regulates the expression of hypothalamus-pituitary-adrenal axis-related genes in response to acute restraint stress
- (2018) Adrián Viudez-Martínez et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
- (2018) Sophie A. Millar et al. Frontiers in Pharmacology
- Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia
- (2018) Tibor Stark et al. NEUROPHARMACOLOGY
- Extinction of avoidance behavior by safety learning depends on endocannabinoid signaling in the hippocampus
- (2017) Vincenzo Micale et al. JOURNAL OF PSYCHIATRIC RESEARCH
- TRPV1 Regulates Stress Responses through HDAC2
- (2017) Sung Eun Wang et al. Cell Reports
- Cannabinoid Modulation of the Stressed Hippocampus
- (2017) Franciele F. Scarante et al. Frontiers in Molecular Neuroscience
- Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors
- (2017) Eva Martínez-Pinilla et al. Frontiers in Pharmacology
- Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
- (2017) Antonio W. Zuardi et al. Frontiers in Pharmacology
- The Role of the Endocannabinoid System in the Brain–Gut Axis
- (2016) Keith A. Sharkey et al. GASTROENTEROLOGY
- Entwicklung und Validierung des Subklinischen Stresssymptom-Questionnaire SSQ-25
- (2016) E. Helms et al. NERVENARZT
- Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents
- (2016) Pius S. Fasinu et al. PHARMACOTHERAPY
- Understanding the burnout experience: recent research and its implications for psychiatry
- (2016) Christina Maslach et al. World Psychiatry
- Endocannabinoids and stress
- (2016) Caitlin J. Riebe et al. STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS
- Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
- (2015) John M McPartland et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
- (2015) R B Laprairie et al. BRITISH JOURNAL OF PHARMACOLOGY
- Active endocannabinoids are secreted on extracellular membrane vesicles
- (2015) M. Gabrielli et al. EMBO REPORTS
- Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users
- (2015) Chandni Hindocha et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Fatty Acid-binding Proteins (FABPs) Are Intracellular Carriers for Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
- (2015) Matthew W. Elmes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neurobiological Interactions Between Stress and the Endocannabinoid System
- (2015) Maria Morena et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol as a Potential Treatment for Anxiety Disorders
- (2015) Esther M. Blessing et al. Neurotherapeutics
- Regulatory role of the cannabinoid CB2receptor in stress-induced neuroinflammation in mice
- (2014) S Zoppi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid receptor type 1 receptors on GABAergic vs. glutamatergic neurons differentially gate sex-dependent social interest in mice
- (2014) Ana Luisa B. Terzian et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Stress regulates endocannabinoid-CB1 receptor signaling
- (2014) Cecilia J. Hillard SEMINARS IN IMMUNOLOGY
- Heart rate variability and its neural correlates during emotional face processing in social anxiety disorder
- (2013) Michael Gaebler et al. BIOLOGICAL PSYCHOLOGY
- The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system
- (2013) Alline C. Campos et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Cannabinoid CB1 Receptor in Dorsal Telencephalic Glutamatergic Neurons: Distinctive Sufficiency for Hippocampus-Dependent and Amygdala-Dependent Synaptic and Behavioral Functions
- (2013) S. Ruehle et al. JOURNAL OF NEUROSCIENCE
- Cannabinoids Ameliorate Impairments Induced by Chronic Stress to Synaptic Plasticity and Short-Term Memory
- (2013) Hila Abush et al. NEUROPSYCHOPHARMACOLOGY
- The Combined Propranolol/TSST Paradigm – A New Method for Psychoneuroendocrinology
- (2013) Julie Andrews et al. PLoS One
- Cannabidiol enhances consolidation of explicit fear extinction in humans
- (2013) Ravi K. Das et al. PSYCHOPHARMACOLOGY
- Biphasic Effects of Cannabinoids in Anxiety Responses: CB1 and GABAB Receptors in the Balance of GABAergic and Glutamatergic Neurotransmission
- (2012) Alejandro Aparisi Rey et al. NEUROPSYCHOPHARMACOLOGY
- Endocannabinoid system and mood disorders: Priming a target for new therapies
- (2012) Vincenzo Micale et al. PHARMACOLOGY & THERAPEUTICS
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABAA receptors
- (2011) María S García-Gutiérrez et al. BRITISH JOURNAL OF PHARMACOLOGY
- A Randomized, Controlled Trial of Meditation for Work Stress, Anxiety and Depressed Mood in Full-Time Workers
- (2011) R. Manocha et al. Evidence-based Complementary and Alternative Medicine
- The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors
- (2011) Ana Luisa Terzian et al. Frontiers in Behavioral Neuroscience
- Functional Interactions between Stress and the Endocannabinoid System: From Synaptic Signaling to Behavioral Output
- (2010) M. N. Hill et al. JOURNAL OF NEUROSCIENCE
- Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
- (2010) José Alexandre S Crippa et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Preservation of Striatal Cannabinoid CB1 Receptor Function Correlates with the Antianxiety Effects of Fatty Acid Amide Hydrolase Inhibition
- (2010) S. Rossi et al. MOLECULAR PHARMACOLOGY
- Endocannabinoid-mediated modulation of stress responses: Physiological and pathophysiological significance
- (2009) David P. Finn IMMUNOBIOLOGY
- Stress and disorders of the stress system
- (2009) George P. Chrousos Nature Reviews Endocrinology
- Salivary alpha-amylase as a non-invasive biomarker for the sympathetic nervous system: Current state of research
- (2009) U.M. Nater et al. PSYCHONEUROENDOCRINOLOGY
- Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond
- (2008) Roger G. Pertwee ADDICTION BIOLOGY
- Regulation of endocannabinoid signaling by stress: Implications for stress-related affective disorders
- (2008) Boris B. Gorzalka et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats
- (2008) Alline Cristina Campos et al. PSYCHOPHARMACOLOGY
- Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
- (2008) Antonio Waldo Zuardi REVISTA BRASILEIRA DE PSIQUIATRIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More